Public Company News

Tuya Smart Partners with Zeroth to Develop Robot-Driven Smart Living Experiences, Bringing Physical AI into the Home

The collaboration integrates Tuya's AI+IoT capabilities with Zeroth's embodied intelligence expertise, transforming home robots from standalone task executors into intelligent, context-aware household companions. GUANGZHOU, China, June 12, 2026 /PRNewswire/ -- Tuya Smart (NYSE: TUYA; HKEX: 2391)...

2026-06-12 17:05 5822

XPENG X9 Tops Range and Charging Performance in World's Largest EV Test

——  11% above WLTP to 646 km and 12m55s charge secure double victory at NAF El Prix Summer 2026 AMSTERDAM, June 12, 2026 /PRNewswire/ -- The XPENG X9 recorded the largest positive deviation from WLTP range and the fastest charging time among all vehicles tested in the summer edition of El Prix 2...

2026-06-12 17:00 4390

Simcere Pharmaceutical Enters into a Research Collaboration Agreement with Stanford Medicine to Develop Innovative Therapies for Patients with Idiopathic Pulmonary Fibrosis

SHANGHAI, June 12, 2026 /PRNewswire/ -- On May 29, 2026, Pacific Time, Simcere Pharmaceutical Group Limited (2096.HK) entered into a research collaboration agreement with Stanford Medicine to jointly advance an exploratory study in the respiratory field, with the aim of developing innovative ther...

2026-06-12 14:59 5730

Akeso's Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio

HONG KONG, June 11, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that the National Medical Products Administration (NMPA) of China has approved gumokimab(AK111), the company's internally-developed anti-IL-17 monoclonal antibody, for the treatment of adult patients with moderate-to-s...

2026-06-12 09:57 5355

Harbour BioMed Appoints Dr. Dhavalkumar Patel as Scientific Advisor

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 11, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other disease areas, today an...

2026-06-12 09:19 6299

Noah Holdings Limited Announces Results of Annual General Meeting and Payment of Final Dividend and Special Dividend

SINGAPORE, June 11, 2026 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive one-stop advisory services on global investment and asset allocation primarily for global Chinese h...

2026-06-11 21:27 10104

SAIHEAT Expands Business into AI Inference Services, Delivering Tokens of Open Models to Enterprises

SINGAPORE, June 11, 2026 /PRNewswire/ -- SAIHEAT Limited (NASDAQ: SAIH) today announced its strategic expansion into the AI inference services business. It delivers enterprise-level authorizedtoken access to mainstream open-source AI models, with our existing and prospective partners covering Kim...

2026-06-11 20:30 10178

LEIFRAS Co., Ltd. Achieves Multi-Sport School Presence Across All 47 Prefectures in Japan on Its 25th Anniversary

4,500-School Nationwide Network Sets the Stage for Accelerated Expansion in School Club Support, Child Welfare, and Strategic M&A TOKYO, June 11, 2026 /PRNewswire/ -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and ...

2026-06-11 20:30 8344

Nota AI Has Two MoE Quantization Papers Accepted at ICML 2026 Workshop, Demonstrating Global Competitiveness in Large-Scale AI Optimization

* Two papers on MoE-specific quantization algorithms accepted at a workshop held in conjunction with ICML 2026 * Recognition follows Nota AI's overall win at the NVIDIA Nemotron Hackathon * Strengthening core optimization technologies to make large-scale AI models smaller and more efficient ...

2026-06-11 20:00 4917

As AI Infrastructure Takes Center Stage, Neurovia AI Highlights NeuroStream™ and New Leadership at UAE Industry Summit

ABU DHABI, UAE, June 11, 2026 /PRNewswire/ -- Robo.ai Inc. (NASDAQ: AIIO) announced that its wholly-owned subsidiary, Neurovia AI, officially participated in the 2026 UAE Data Center Infrastructure & Cloud Summit as an OFFICIAL AI INFRASTRUCTURE PARTNER. The event, held today in Abu Dhabi, marked...

2026-06-11 18:33 5896

Trip.com Group Limited to Report First Quarter of 2026 Financial Results on June 24, 2026 U.S. Time

SINGAPORE, June 11, 2026 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours and corporate travel management, will announce its financial results for the three months e...

2026-06-11 18:00 6832

CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights

SUZHOU, China, June 11, 2026 /PRNewswire/ -- The clinical datasets presented at ASCO 2026by CStone further validate the trispecific synergistic mechanism of CS2009 and support its potential to become a next-generation immuno-oncology (I/O) backbone therapy. I. Trispecific Design Rationale and Di...

2026-06-11 14:20 5364

Caliway Unveils Latest OI25 Animal Study Data for CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies at ADA 2026, Demonstrating Dual Potential to Attenuate Post-Discontinuation Weight Regain and Improve Metabolic Health

Backed by International Authority — Caliway's latest preclinical data on its proprietary localized fat reduction candidate, CBL-514, in combination with GLP–1R–based weight–loss therapies, were presented at the American Diabetes Association 2026 Scientific Sessions (ADA 2026). The findings were d...

2026-06-11 12:54 4474

Elixiron Immunotherapeutics Reports Positive Phase 2 Interim Results for Enrupatinib: Evidence of Neuroinflammation Reduction and Early Cognitive Benefit in Alzheimer's Disease

CAMBRIDGE, Mass. and TAIPEI, June 10, 2026 /PRNewswire/ -- Elixiron Immunotherapeutics (TPEx: 7871), a clinical-stage biopharmaceutical company pioneering precision immunotherapy for neurodegenerative and autoimmune diseases, today announced positive interim results from its ongoing Phase 2 proo...

2026-06-11 10:56 5493

Harbour BioMed Appoints Dr. Luisa Salter-Cid as Scientific Advisor

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 10, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other disease areas, today an...

2026-06-11 09:52 4144

Lintes Accelerates AI Connectivity Expansion Through Optical Communication and Scalable Manufacturing

* Driven by growing AI demand, Lintes (TWSE: 6715) reported 17.2% YoY Q1 revenue growth and showcased its AI connectivity solutions at COMPUTEX 2026. * Lintes has expanded its R&D since 2025 to fully commit to next-generation products driven by AI demand, including 6.4T CPC and CPO Socket (32T...

2026-06-11 08:50 4521

POP Culture Group Reports Stellar Half-Year Results: Robust Business Growth with Revenue Surging 141% Year-Over-Year

XIAMEN, China, June 10, 2026 /PRNewswire/ -- POP Culture Group Co., Ltd. (Nasdaq: CPOP, "POP Culture" or the "Company"), today announced its unaudited financial results for six months ended December 31, 2025. During the reporting period, the Company achieved significant growth in its core busines...

2026-06-10 21:10 9375

QingSong Health Corp (2661.HK) and Basel Medical Sign Strategic Cooperation Memorandum to Explore AI Healthcare Services in Southeast Asia

BEIJING, June 10, 2026 /PRNewswire/ -- Recently, QingSong Health Corp (2661.HK) andBasel Medical Group Ltd announced the signing of a Memorandum of Strategic Cooperation. The two parties intend to explore cooperation in AI-enabled healthcare services, insurance-related healthcare solutions, and c...

2026-06-10 21:05 6816

NOROO Holdings Advances Commercialization of Bio-Based 3-HP Through Major Korean Government Initiative

* Selected as the lead organization for a major government-backed initiative to accelerate commercialization of bio-based 3-HP through pilot-scale investments. * Establishing an integrated R&D value chain spanning feedstock development, production, and downstream applications through collabor...

2026-06-10 21:00 4866

Vatech Completes Full-Portfolio EU MDR Certification

Certification covers all three dental imaging categories and every 2026 model launch HWASEONG, South Korea, June 10, 2026 /PRNewswire/ -- Vatech (KOSDAQ: 043150), a global leader in dental imaging, today announced the completion of EU Medical Device Regulation (MDR; Regulation (EU) 2017/745) cer...

2026-06-10 21:00 3945
1 ... 9101112131415 ... 763